When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

Published Date: 15 Dec 2023

Improvements in 2-year PFS and OS, but not for primary refractory illness.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer

2.

Acupuncture may alleviate nocturia in men treated for prostate cancer

3.

Inadvertent lung cancer screening results are discussed in a new study.

4.

Patients face high out-of-pocket costs after incident cancer diagnosis

5.

Rucaparib Delays Next Lines of Therapy in Ovarian Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot